NCT06589765View on ClinicalTrials.gov

A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

PHASE3RecruitingINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

February 18, 2026

Study Completion Date

July 18, 2026

Conditions

Type 2 Diabetes

Interventions

DRUG

HRS-7535 tablet

HRS-7535 tablet

DRUG

dapagliflozin tablet

dapagliflozin tablet

Trial Locations (1)

100730

RECRUITING

Beijing Hospital, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY